The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Elizabeth (Liz) Wager is a freelance consultant and trainer with a background in publishing and medical writing who has worked on 6 continents. She chaired the Committee on Publication Ethics (2009-2012) and is a member of the Ethics Committees of the BMJ and the World Association of Medical Editors. She is a co-author of various COPE guidelines, Good Publication Practice for Pharmaceutical Companies, and wrote ‘Getting Research Published: An A to Z of Publication Strategy’ (2nd edition 2010).
Jennifer K. Wagner earned her JD from the University of North Carolina and her PhD in Anthropology from Penn State University. She completed post-doctoral research appointments at Duke University's Institute for Genome Sciences & Policy and the University of Pennsylvania's Center for the Integration of Genetic Healthcare Technologies. She served as the 2014-2015 AAAS Science & Engineering Congressional Fellow. In addition to her research, she has been a licensed, practicing attorney in PA since 2007.
Recipient of the Wellcome Trust Senior Investigator Award (2011) and an ERC Advanced Grant (2011). Director of the European Workshop on Cell Death (EWCD) Charity.
I am a statistician who works with biological and genomic datasets to understand the mechanisms underlying human disease and identify possible treatments. My main focus is on autoimmune diseases.
My background in is maths, and I gained my PhD in statistical genetics at the London School of Hygiene and Tropical Medicine in 2003. I now work at the Cambridge Institute for Medical Research (CIMR), where I am head of statistics in the Diabetes and Inflammation Laboratory.
Dr. Wallen earned a B.S. and Ph.D. from the Univ. of Illinois. He studied supercritical fluids at Pacific Northwest National Laboratory using a variety of spectroscopic techniques including NMR, XAFS, Raman and FTIR spectroscopy. The author of over 50 refereed papers his work has been highlighted in Science and C & E News. He has served as a reviewer for top journals and government science panels. Dr. Wallen is currently on the staff at Florida Polytechnic University. His research interests are on the implementation/growth of green nanotechnology, chemistry and sustainable processes applied to materials synthesis, remediation, recycling and analysis. Projects converting biomass to carbon quantum dots for sensing and electronics; nanophotocatalytic oxidation of wastewater; and use of carbohydrates and their derivatives for nanomaterials preparation are ongoing as are development of microvolume, high-pressure continuous flow systems (HP-CFS) to prepare and analyze functional, sustainable nanomaterials. He recently developed the concept of a circular economy paradigm for implementing university science laboratories which led to an Award for Innovation in 2016 by the Campus Safety, Health & Environmental Managers Association (CSHEMA). At the 21st Annual Green Chemistry & Engineering Conference, Dr. Wallen won the 2017 Applied Separations Prime Grant for commitment to teaching Supercritical Fluids. In his spare time he enjoys his family, playing music and outdoor activities.
Dr Walley was appointed as Senior Lecturer in Human Genomics in 2015. Prior to this, he was at Imperial College London where he held the posts of Lecturer in Complex Human Genetics (2005-2015) and Genome Centre Manager (2003-2005).
At Imperial College London, Dr Walley’s teaching roles included Course Director of the MSc in Human Molecular Genetics and Co-Course Director of the short course “Principles of Genomic Medicine”. He was also Module leader for the “Omics Techniques” module for the MSc in Genomic Medicine and Lecturer and examiner for the “Genetics” module of the first year MBBS/BMS undergraduate and graduate entry MBBS degree courses. He was awarded the Postgraduate Certificate in Advanced Student Learning and Teaching from Imperial College London in 2007.
Before moving to Imperial College London, he held three consecutive postgraduate research posts at the University of Oxford, working in the Wellcome Trust Centre for Human Genetics, the John Radcliffe Hospital and the Weatherall Institute of Molecular Medicine.
Dr Walley obtained both his undergraduate honours degree in biochemistry and his Ph.D. in virology from the University of Oxford.
Professor in Genetics, University of Otago. Past Vice-President, Society for the Study of Evolution. Past Convenor of EEB Panel, Marsden Fund, New Zealand. Past Marsden Fund Council Member. Associate Editor: Pacific Conservation Biology. Past Associate Editor: Evolution, Molecular Ecology. Temminck Fellow, National Museum of Natural History, Leiden, 2008, 2011. Research Interests: hybrid zones, biogeography, molecular evolution, molecular systematics, conservation genetics. Current projects: Adaptive evolution of a larval glycoprotein in galaxiid fishes (with Luca Jovine, Karolinska Institutet); New Zealand biogeography (with Jon Waters & Dave Craw, Otago); Minimising adaptation to captivity for conservation of threatened species (with Catherine Grueber, Univ Sydney); Molecular systematics of European newts (with Pim Arntzen, National Museum of Natural History, Leiden)
Director of Science at Sea-Bird Scientific, an international supplier of oceanographic and aquatic research and monitoring instruments. Dr. Walsh conducts research on and with optical and biogeochemical instruments and data systems. Prior to joining Sea-Bird, Dr. Walsh was a research scientist and professor at Texas A&M University and Oregon State University, participating in many large international and interdisciplinary research efforts, and authoring more than twenty five widely cited research papers.
Research interest include:
* Particle dynamics, including the use of the particle field to understand biogeochemical processes and the influence of physical forcing on those processes.
* Carbon fluxes and fates including predictive modeling.
* Development of instrumentation and systems for operational and climate scale monitoring of biogeochemical processes in marine and fresh waters.
* Development of quality control algorithms for autonomous and remote instruments and date sets.
* Developing in situ instrumentation and methodologies for crude oil detection and discrimination from non-oil organic substances.
Established Professor of Vascular Surgery, NUI Galway, Ireland; Associate Director Health Research Board Clinical Research Facility Galway, Ireland; Editor, Cochrane Vascular Group.
Dr. Jianjun Wang is Professor of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, and Senior Researcher of University of Helsinki. He studies microbial biogeography and global change. His main topics are related to the questions on how microbial diversity and community composition varied within Earth’s surface and subsurface, especially aquatic environments. He is using self-obtained large microbial data sets, in-situ experiments, as well as modeling methods to achieve these answers.
Associate professor of Pediatrics, Microbiology, Immunology, and Parasitology with the research emphasis on molecular mechanisms of fungal pathogenesis.
I am an Associate Professor at Department of Biomedical Informatics and Department of Computer Science at Stony Brook University. I received my Ph.D. in Computer Science from University of California, Los Angeles, and M.S. and B.S. in Engineering Physics from Tsinghua University, China. Prior to joining Stony Brook University, I was an assistant professor at Emory University. I was a research scientist at Siemens Corporate Research (Princeton, NJ) before joining Emory University.
My research goal on big data management and analytics is to address the research challenges for delivering effective, scalable and high performance software systems for managing, querying and mining complex big data at multiple dimensions, including 2D and 3D spatial and imaging data, temporal data, spatial-temporal data, and sequencing data. My research goal on biomedical informatics is to develop novel methods and software systems to optimize the acquisition, extraction, management, and mining of biomedical data with much improved efficiency, interoperability, accuracy, and usability to support biomedical research and the healthcare enterprise.